Etiopathogenesis of primary sclerosing cholangitis

Primary sclerosing cholangitis(PSC) is a chronic cholestatic liver disease of unknown etiology but lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for this disease.Associations with inflammatory bowel disease(IBD) especially ulcerative colitis(UC),and with particular...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 14; no. 21; pp. 3350 - 3359
Main Authors Chapman, Roger, Cullen, Sue
Format Journal Article
LanguageEnglish
Published United States Department of Gastroenterology,John Radcliffe Hospital,Headington,Oxford OX3 9DU,United Kingdom 07.06.2008
The WJG Press and Baishideng
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Primary sclerosing cholangitis(PSC) is a chronic cholestatic liver disease of unknown etiology but lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for this disease.Associations with inflammatory bowel disease(IBD) especially ulcerative colitis(UC),and with particular autoimmune diseases,as well as the genetic associations further suggest PSC may be an immune-mediated disease.The immunogenetics of PSC have been the subject of active research and several HLA and non-HLA associated genes have been implicated in the development of the disease.Lymphocytes derived from the inflamed gut may enter the liver via the enterohepatic circulation to cause hepatic disease.PSC may be triggered in genetically susceptible individuals by infections or toxins entering the portal circulation through a permeable colon and hence evoking an abnormal immune response.
Bibliography:Biliaryepithelial cells
Autoantibody; Immunogenetics; Biliaryepithelial cells; T cell receptor; Lymphocytes
Immunogenetics
T cell receptor
R657.4
Lymphocytes
14-1219/R
Autoantibody
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Telephone: +44-1865-228756
Fax: +44-1865-751100
Correspondence to: Sue Cullen, MD, Department of Gastroen-terology, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom. sue.cullen@buckshosp.nhs.uk
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.14.3350